Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

One-size-fits-all hats are okay, but one-size-fits-all medical treatments don't cut it. A new study shows that drug treatment ...

During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...